0001162044-20-001430.txt : 20201124 0001162044-20-001430.hdr.sgml : 20201124 20201124142238 ACCESSION NUMBER: 0001162044-20-001430 CONFORMED SUBMISSION TYPE: NT NPORT-P PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20201124 PERIOD START: 20210331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYSA SERIES TRUST CENTRAL INDEX KEY: 0001027657 IRS NUMBER: 161517067 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: NT NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07963 FILM NUMBER: 201342730 BUSINESS ADDRESS: STREET 1: 507 PLUM STREET SUITE 120 STREET 2: . CITY: SYRACUSE STATE: NY ZIP: 13204 BUSINESS PHONE: (315) 251-1101 MAIL ADDRESS: STREET 1: 507 PLUM STREET SUITE 120 STREET 2: . CITY: SYRACUSE STATE: NY ZIP: 13204 FORMER COMPANY: FORMER CONFORMED NAME: NEW YORK STATE OPPORTUNITY FUNDS DATE OF NAME CHANGE: 19961126 0001027657 S000004908 NYSA Fund C000013264 NYSA Fund NYSAX NPORT-P 1 primary_doc.xml NPORT-P false 0001027657 XXXXXXXX S000004908 C000013264 NYSA SERIES TRUST 811-07963 0001027657 549300HGVY2IMD2RFV95 507 Plum Street Suite 120 Syracuse 13204 315-251-1101 NYSA Fund S000004908 549300W8D7D8IYFXGT87 2021-03-31 2020-08-31 Y 1704636.82 34354.84 1670281.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 500.00 N N/A N/A Central New York Raceway Park Inc. N/A 25000.00 NS USD 0.00 0.00 Long EC CORP US N 1 N N N Federated Hermes Money Market Obligations Trust 25490005VWJDWX717014 Federated Treasury Obligation Fund - Insitutional Shares 60934N500 1223143.60 NS USD 1223143.60 73.23 Long STIV RF US N 1 N N N Ligand Pharmaceuticals, Inc. 5493008K7TB0IKP37H79 Ligand Pharmaceuticals Inc. Class B 53220K504 500.00 NS USD 51000.00 3.05 Long EC CORP US N 1 N N N N/A N/A Transluminal Technologies LLC N/A 84332.00 NS USD 400577.00 23.98 Long EC CORP US N 2 N N N 2020-08-31 NYSA Series Trust /s/ Robert Cuculich Robert Cuculich President